Precision medical treatment, diagnosis comes first. As the "gold standard" for disease diagnosis, pathological diagnosis is a terminal diagnosis that cannot be replaced by any means at present, and is also the most reliable basis for guiding the clinical treatment of tumors and evaluating prognosis. Its importance in realizing individualized precision medicine is self-evident. Quality has always been the lifeline of pathological diagnosis, and standardized, refined and intelligent quality management is the key to the pathology department to ensure the accurate and efficient pathological diagnosis.
HD University Affiliated Cancer Hospital Daughter Department is the department that has been ranked first in the ranking of the best specialist reputation pathology departments in Chinese hospitals for 11 consecutive years. Professor Wang Jian, Department of Pathology, pointed out that quality control and management run through all aspects of the construction of the entire pathology laboratory. In terms of the soft power of personnel construction, the department has taken multiple measures such as sub-specialty construction, professional division of labor, regular academic activities, discussion of difficult cases, and clinical MDT multidisciplinary diagnosis and treatment system to improve the quality control system and system construction. In terms of equipment hard power, iterative upgrades cannot be ignored. The department uses innovative technologies to promote the automation, standardization and standardization of pathological detection by introducing the most advanced pathological detection platform.
At the same time, with the continuous development of precision medicine, more and more companion diagnostic tests can be achieved through routine pathological immunohistochemistry tests. Therefore, establishing a more complete immunohistochemistry quality control management process can provide more accurate information for pathological diagnosis and medication guidance. Professor Li Yuan of the Department of Pathology of Fudan University Affiliated Cancer Hospital introduced that taking lung cancer as an example, especially the samples of advanced lung cancer are mostly punctured samples, with small samples and small tumor cells. The quality control of each link may affect the accuracy of diagnosis results. Standardized pathological detection is crucial to the accuracy of staining and interpretation. For example, the selection and verification of positive control in quality control management and the management of batch numbers have taken a lot of time and energy from the department technical teachers. Therefore, achieving traceability of the detection samples is also an important measure for pathology laboratories to optimize quality control management.
Recently, the Department of Pathology of Fudan University Affiliated Cancer Hospital, based on the original BenchMark series fully automatic staining platform, took the lead in introducing the first BenchMark ULTRA PLUS platform in the country, further strengthening the standardized modern management of clinical pathology laboratories, promoting the high-quality development of clinical pathological detection and diagnosis, and thus providing more patients with high-quality precision medical services.
The new BenchMark ULTRA PLUS platform is unveiled at this CIIE. This innovative fully automatic immunohistochemistry and in situ hybrid staining platform by Roche Diagnosed has achieved a triple innovation in efficiency, quality and flexibility, helping to standardize quality management in pathology and continuously empowering individualized precision medicine. While continuing the mature technologies and advantages of the BenchMark series platforms, it has achieved comprehensive upgrades, and with optimized workflow, stable dyeing quality and flexible solutions, it helps pathologist to perform more complete and efficient quality control, giving it a more standardized and intelligent laboratory management experience.
The first BenchMark ULTRA PLUS platform in the country was launched in the Department of Pathology, Fudan University Affiliated Cancer Hospital (Pudong Campus)
To meet the quality control and management needs of pathological laboratories, the BenchMark ULTRA PLUS platform has carried out a number of innovations to provide a more optimized workflow and a more convenient operating experience for pathological immunohistochemistry and in-situ hybridization detection. At the same time, with the optimized VSS management software, pathologists can remotely view the detailed quality control information of each sample anytime and anywhere, and promptly feedback on the staining problems found in the reading film, allowing the pathology laboratory to truly break the limitations of time and distance and achieve more intuitive and efficient information sharing and quality control.
(Pan Jiayi)
